Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
April 3, 2019
Cabaletta Bio Appoints Distinguished Immunotherapist and Cell Therapy Expert, Catherine Bollard, M.D., to its Board of Directors
March 25, 2019
Arvinas Announces Initiation of Patient Dosing in the First Phase 1 Clinical Trial of PROTAC™ Protein Degrader, ARV-110
March 11, 2019
RareCyte Expands Liquid Biopsy Offerings With The RarePlex™ CTC Developer Kit For Custom Biomarkers, And Introduces The Next Generation CytePicker® Cell Retrieval Module for Single Cell and Tissue Micro-Region Retrieval
February 27, 2019
Aprea Therapeutics Adds New Investor to Series C Financing
February 14, 2019
Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia
February 13, 2019
5AM Ventures Closes Two Life Science Venture Capital Funds
January 31, 2019
Audentes Therapeutics Announces Next Steps in the Development of AT132 to Treat XLMTM Following Collaborative Initial Meeting with FDA Under RMAT Designation
January 31, 2019
Kinestral Technologies Secures Over $100 Million in Series D Funding Led by SK Holdings
January 7, 2019
Homology Medicines Achieves 2018 Goals and Prepares PKU Gene Therapy Program for the Clinic with Initial Data Expected in 2019
January 7, 2019
Audentes Therapeutics Reports on Recent Progress and Outlines 2019 Key Priorities
« Previous Page
1
…
54
55
56
57
58
…
103